---
created: 2025-04-13
updated: 2025-04-13T10:53
id: tXZ|54.x<U
specialty: infect
specialty_id: 73
tags:
  - source/ak-original-decks::step-1::lolnotacop::bugs
  - "source/ak-step1-v11:": 
  - theme/b&b::13-infectious-disease::04-fungi::03-opportunistic-fungal-infections
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::03-mycology::03-opportunistic-fungal-infections
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::03-mycology::03-opportunistic-fungal-infections::candida-albicans
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::08-microbiology::29-fungi
  - "source/ak-step1-v11:": 
  - theme/physeo::06-micro::03-fungi::08-candida-albicans
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::04-antifungals::04-echinocandins
  - "source/ak-step1-v11:": 
  - theme/sketchymicro::02-fungi::03-opportunistic-fungal-infections::01-candida-albicans
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::200-299::277
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
Systemic (disseminated) infections of **Candida albicans** are treated with **Amphotericin B** and **Caspofungin**

---

# Answer
Caspofungin's MOA = inhibits synthesis of the polysaccharide glucan, an essential component of the fungal cell wall  Whereas Amphotericin B binds to ergosterol *fungal cell membrane* == pore formation & cell lysis